Today: 20 July 2026
Lumentum stock price jumps premarket as Nvidia puts $2 billion into LITE in AI optics push
3 March 2026
1 min read

Lumentum stock price jumps premarket as Nvidia puts $2 billion into LITE in AI optics push

New York, March 3, 2026, 06:42 (EST) — Premarket

  • Lumentum shares jumped in premarket trading, boosted after Nvidia revealed a financing-and-supply agreement connected to AI data center optics.
  • The $2 billion investment comes as new convertible preferred stock, according to a filing, with conversion to common shares possible once the required antitrust waiting period ends.

Lumentum Holdings Inc (LITE) jumped $82.55 to trade at $783.25 before the bell Tuesday, marking an 11.8% premarket gain in the U.S.

Nvidia is putting $2 billion apiece into Lumentum and fellow optical player Coherent, aiming to bring photonics—moving data with light instead of electricity—further into the guts of AI data centers.

The AI buildout faces a fresh set of constraints. These days, it’s not just about GPUs—optical links, lasers, and the packaging that shuttles data quickly are tightening the screws too, especially as power demands climb.

Nvidia’s investment in Lumentum came via a new Series A convertible preferred stock, according to a regulatory filing. The shares were sold privately. Lumentum noted the preferred stock converts to common stock on a one-for-one basis, but only after the Hart-Scott-Rodino antitrust waiting period ends or is terminated.

Nvidia outlined a non-exclusive deal in the joint statement, detailing multi-year supply commitments, future access to advanced laser component capacity, and purchase obligations. “AI has reinvented computing,” said Nvidia CEO Jensen Huang. Lumentum CEO Michael Hurlston added that the company is “also investing in a new fabrication facility.” Fintel

Stifel bumped its price target on Lumentum up to $800 from $480, sticking with a Buy rating. The firm pointed to what it considers increasing networking demand driven by AI rollouts.

Yet several factors could still throw things off. The antitrust review will decide the conversion timeline, and getting the new U.S. fab up and running might not deliver volume shipments overnight. Plus, since the deal isn’t exclusive, orders could shift if demand for AI falters.

Lumentum’s upcoming investor briefing at the Optical Fiber Communication Conference in Los Angeles, set for March 17, is the next key event on traders’ radar. They’ll be eyeing any fresh details on capacity plans, and especially on how fast those purchase commitments start contributing to revenue.

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Stock Market Today

  • Bank of Nova Scotia stands out as a Canadian blue-chip dividend stock for sustained income
    July 19, 2026, 8:45 PM EDT. Bank of Nova Scotia (TSX:BNS), known as Scotiabank, remains a leading Canadian dividend stock fit for long-term income investors. In Q2 fiscal 2026, the bank increased its dividend by $0.04 per share and returned $7.5 billion to shareholders in buybacks and dividends. Adjusted earnings reached $2.7 billion ($2.02 per share), reflecting a 16% rise in pretax pre-provision earnings year-over-year. Return on equity was 13.2%, with plans to exceed 14% by 2027. Scotiabank operates across Canada, the United States, and Mexico, leveraging expansion in Latin America. Its international segment posted a 12% earnings gain, led by Mexico revenue growth of 8%. Wealth management achieved $4.7 billion in sales with a 17.9% return on equity. CEO Scott Thomson noted the addition of 400,000 new retail customers and cited a 35% total shareholder return expectation for 2025.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 03.03.2026

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom
Next Story

Eli Lilly stock slips again as April orforglipron decision and FDA GLP-1 ad crackdown loom

Go toTop